Imatinib accelerates progenitor cell-mediated liver regeneration in choline-deficient ethionine-supplemented diet-fed mice

András Rókusz, Edina Bugyik, Vanessza Szabó, Armanda Szücs, Sándor Paku, P. Nagy, Katalin Dezső

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Severe chronic hepatic injury can induce complex reparative processes. Ductular reaction and the appearance of small hepatocytes are standard components of this response, which is thought to have both adverse (e.g. fibrosis, carcinogenesis) and beneficial (regeneration) consequences. This complex tissue reaction is regulated by orchestrated cytokine action. We have investigated the influence of the tyrosine kinase inhibitor imatinib on a regenerative process. Ductular reaction was induced in mice by the widely used choline-deficient ethionine-supplemented diet (CDE). Test animals were treated daily with imatinib. After 6 weeks of treatment, imatinib successfully reduced the extent of ductular reaction and fibrosis in the CDE model. Furthermore, the number of small hepatocytes increased, and these cells had high proliferative activity, were positive for hepatocyte nuclear factor 4 and expressed high levels of albumin and peroxisome proliferator-activated receptor alpha. The overall functional zonality of the hepatic parenchyma (cytochrome P450 2E1 and glucose 6 phosphatase activity; endogenous biotin content) was maintained. The expression of platelet-derived growth factor receptor beta, which is the major target of imatinib, was downregulated. The anti-fibrotic activity of imatinib has already been reported in several experimental models. Additionally, in the CDE model imatinib was able to enhance regeneration and preserve the functional arrangement of hepatic lobules. These results suggest that imatinib might promote the recovery of the liver following parenchymal injury through the inhibition of platelet-derived growth factor receptor beta.

Original languageEnglish
Pages (from-to)389-396
Number of pages8
JournalInternational Journal of Experimental Pathology
Volume97
Issue number5
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Ethionine
Liver Regeneration
Choline
Stem Cells
Diet
Platelet-Derived Growth Factor beta Receptor
Liver
Regeneration
Hepatocytes
Hepatocyte Nuclear Factor 4
Fibrosis
PPAR alpha
Cytochrome P-450 CYP2E1
Glucose-6-Phosphatase
Wounds and Injuries
Biotin
Imatinib Mesylate
Protein-Tyrosine Kinases
Albumins
Carcinogenesis

Keywords

  • choline-deficient ethionine-supplemented diet
  • ductular reaction
  • imatinib
  • liver fibrosis
  • liver regeneration
  • PDGFR-β

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Imatinib accelerates progenitor cell-mediated liver regeneration in choline-deficient ethionine-supplemented diet-fed mice. / Rókusz, András; Bugyik, Edina; Szabó, Vanessza; Szücs, Armanda; Paku, Sándor; Nagy, P.; Dezső, Katalin.

In: International Journal of Experimental Pathology, Vol. 97, No. 5, 01.10.2016, p. 389-396.

Research output: Contribution to journalArticle

Rókusz, András ; Bugyik, Edina ; Szabó, Vanessza ; Szücs, Armanda ; Paku, Sándor ; Nagy, P. ; Dezső, Katalin. / Imatinib accelerates progenitor cell-mediated liver regeneration in choline-deficient ethionine-supplemented diet-fed mice. In: International Journal of Experimental Pathology. 2016 ; Vol. 97, No. 5. pp. 389-396.
@article{bcbd6b550d264875b732a7f4b9ea6d22,
title = "Imatinib accelerates progenitor cell-mediated liver regeneration in choline-deficient ethionine-supplemented diet-fed mice",
abstract = "Severe chronic hepatic injury can induce complex reparative processes. Ductular reaction and the appearance of small hepatocytes are standard components of this response, which is thought to have both adverse (e.g. fibrosis, carcinogenesis) and beneficial (regeneration) consequences. This complex tissue reaction is regulated by orchestrated cytokine action. We have investigated the influence of the tyrosine kinase inhibitor imatinib on a regenerative process. Ductular reaction was induced in mice by the widely used choline-deficient ethionine-supplemented diet (CDE). Test animals were treated daily with imatinib. After 6 weeks of treatment, imatinib successfully reduced the extent of ductular reaction and fibrosis in the CDE model. Furthermore, the number of small hepatocytes increased, and these cells had high proliferative activity, were positive for hepatocyte nuclear factor 4 and expressed high levels of albumin and peroxisome proliferator-activated receptor alpha. The overall functional zonality of the hepatic parenchyma (cytochrome P450 2E1 and glucose 6 phosphatase activity; endogenous biotin content) was maintained. The expression of platelet-derived growth factor receptor beta, which is the major target of imatinib, was downregulated. The anti-fibrotic activity of imatinib has already been reported in several experimental models. Additionally, in the CDE model imatinib was able to enhance regeneration and preserve the functional arrangement of hepatic lobules. These results suggest that imatinib might promote the recovery of the liver following parenchymal injury through the inhibition of platelet-derived growth factor receptor beta.",
keywords = "choline-deficient ethionine-supplemented diet, ductular reaction, imatinib, liver fibrosis, liver regeneration, PDGFR-β",
author = "Andr{\'a}s R{\'o}kusz and Edina Bugyik and Vanessza Szab{\'o} and Armanda Sz{\"u}cs and S{\'a}ndor Paku and P. Nagy and Katalin Dezső",
year = "2016",
month = "10",
day = "1",
doi = "10.1111/iep.12209",
language = "English",
volume = "97",
pages = "389--396",
journal = "International Journal of Experimental Pathology",
issn = "0959-9673",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Imatinib accelerates progenitor cell-mediated liver regeneration in choline-deficient ethionine-supplemented diet-fed mice

AU - Rókusz, András

AU - Bugyik, Edina

AU - Szabó, Vanessza

AU - Szücs, Armanda

AU - Paku, Sándor

AU - Nagy, P.

AU - Dezső, Katalin

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Severe chronic hepatic injury can induce complex reparative processes. Ductular reaction and the appearance of small hepatocytes are standard components of this response, which is thought to have both adverse (e.g. fibrosis, carcinogenesis) and beneficial (regeneration) consequences. This complex tissue reaction is regulated by orchestrated cytokine action. We have investigated the influence of the tyrosine kinase inhibitor imatinib on a regenerative process. Ductular reaction was induced in mice by the widely used choline-deficient ethionine-supplemented diet (CDE). Test animals were treated daily with imatinib. After 6 weeks of treatment, imatinib successfully reduced the extent of ductular reaction and fibrosis in the CDE model. Furthermore, the number of small hepatocytes increased, and these cells had high proliferative activity, were positive for hepatocyte nuclear factor 4 and expressed high levels of albumin and peroxisome proliferator-activated receptor alpha. The overall functional zonality of the hepatic parenchyma (cytochrome P450 2E1 and glucose 6 phosphatase activity; endogenous biotin content) was maintained. The expression of platelet-derived growth factor receptor beta, which is the major target of imatinib, was downregulated. The anti-fibrotic activity of imatinib has already been reported in several experimental models. Additionally, in the CDE model imatinib was able to enhance regeneration and preserve the functional arrangement of hepatic lobules. These results suggest that imatinib might promote the recovery of the liver following parenchymal injury through the inhibition of platelet-derived growth factor receptor beta.

AB - Severe chronic hepatic injury can induce complex reparative processes. Ductular reaction and the appearance of small hepatocytes are standard components of this response, which is thought to have both adverse (e.g. fibrosis, carcinogenesis) and beneficial (regeneration) consequences. This complex tissue reaction is regulated by orchestrated cytokine action. We have investigated the influence of the tyrosine kinase inhibitor imatinib on a regenerative process. Ductular reaction was induced in mice by the widely used choline-deficient ethionine-supplemented diet (CDE). Test animals were treated daily with imatinib. After 6 weeks of treatment, imatinib successfully reduced the extent of ductular reaction and fibrosis in the CDE model. Furthermore, the number of small hepatocytes increased, and these cells had high proliferative activity, were positive for hepatocyte nuclear factor 4 and expressed high levels of albumin and peroxisome proliferator-activated receptor alpha. The overall functional zonality of the hepatic parenchyma (cytochrome P450 2E1 and glucose 6 phosphatase activity; endogenous biotin content) was maintained. The expression of platelet-derived growth factor receptor beta, which is the major target of imatinib, was downregulated. The anti-fibrotic activity of imatinib has already been reported in several experimental models. Additionally, in the CDE model imatinib was able to enhance regeneration and preserve the functional arrangement of hepatic lobules. These results suggest that imatinib might promote the recovery of the liver following parenchymal injury through the inhibition of platelet-derived growth factor receptor beta.

KW - choline-deficient ethionine-supplemented diet

KW - ductular reaction

KW - imatinib

KW - liver fibrosis

KW - liver regeneration

KW - PDGFR-β

UR - http://www.scopus.com/inward/record.url?scp=85006448700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006448700&partnerID=8YFLogxK

U2 - 10.1111/iep.12209

DO - 10.1111/iep.12209

M3 - Article

VL - 97

SP - 389

EP - 396

JO - International Journal of Experimental Pathology

JF - International Journal of Experimental Pathology

SN - 0959-9673

IS - 5

ER -